Is Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer ' s Drug Decision?

The FDA will now hold an advisory committee meeting to discuss Eli Lilly's Alzheimer's drug, donanemab. Is Eli Lilly stock a buy or a sell? The post Is Eli Lilly Stock A Buy Or A Sell After FDA Delays Its Alzheimer's Drug Decision? appeared first on Investor's Business Daily.#fda #elililly #iselilillystock

Source: Reuters: Health - March 10, 2024 Category: Consumer Health News Source Type: news